Project List
List projects.
Fields
id (integer)
Primary key.
Expansions
To activate relation expansion add the desired fields as a comma separated
list to the expand query parameter like this:
?expand=<field>,<field>,<field>,...
The following relational fields can be expanded:
organizationcategorytypepartner_functionmanagercontactstatusgrantresearcheventstudylanguageprogramfunders
Filters
To filter for exact value matches:
?<fieldname>=<value>
Possible exact filters:
organizationcategorymanagercontactstatusgrantresearchstudylanguagefundersprogram
For advanced filtering use lookups:
?<fieldname>__<lookup>=<value>
All fields with advanced lookups can also be used for exact value matches as described above.
Possible advanced lookups:
begin_planned:gt,gte,lt,ltebegin_effective:gt,gte,lt,lteend_planned:gt,gte,lt,lteend_effective:gt,gte,lt,lte
GET /v1/research/project/?format=api&offset=80&ordering=-begin_effective
{ "count": 2140, "next": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=100&ordering=-begin_effective", "previous": "https://api-test.medunigraz.at/v1/research/project/?format=api&limit=20&offset=60&ordering=-begin_effective", "results": [ { "id": 8369, "title": { "de": "EMBRACE", "en": "EMBRACE - pan-European Management of Biological toxin\r\nincidents through standaRdisAtion initiatives for Crisis\r\nresponse Enhancement ”\r\n" }, "short": "EMBRACE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2027-09-30T02:00:00+02:00", "end_effective": "2027-09-30T02:00:00+02:00", "assignment": "2024-08-22T12:03:41+02:00", "program": null, "subprogram": null, "organization": 14019, "category": 10, "type": 10, "partner_function": 2, "manager": 115441, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8369-115441-10" ] }, { "id": 8525, "title": { "de": "Metabolische Kontrolle von Altern und Krankheit", "en": "Metabolic control of aging and disease" }, "short": "MetAGE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2023-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2028-09-30T02:00:00+02:00", "end_effective": "2029-09-30T02:00:00+02:00", "assignment": "2024-11-21T16:12:41+01:00", "program": 125, "subprogram": null, "organization": 14013, "category": 10, "type": 10, "partner_function": 4, "manager": 51860, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "COE14", "ethics_committee": null, "edudract_number": null, "persons": [ "8525-120872-12", "8525-124053-12", "8525-70922-12", "8525-51860-10" ] }, { "id": 8624, "title": { "de": "CoE MetAge – Zusatzfinanzierung", "en": "CoE MetAge – Zusatzfinanzierung" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2029-09-30T02:00:00+02:00", "end_effective": "2029-09-30T02:00:00+02:00", "assignment": "2025-01-24T16:08:57+01:00", "program": null, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 2, "manager": 94512, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": "ABT12-338847/2024-12", "ethics_committee": null, "edudract_number": null, "persons": [ "8624-94512-10" ] }, { "id": 8413, "title": { "de": "Mikrofluidischer Kanzinogenese Chip als MausXenograft Ersatz Replace mice xenografts by MIcrofluidic CancerogEnesis Chips", "en": "Microfluidic carcinogenesis chip as mouse xenograft replacement Replace mice xenografts by MIcrofluidic CancerogEnesis Chips" }, "short": "ReplaceMice", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2027-09-30T02:00:00+02:00", "end_effective": "2027-09-30T02:00:00+02:00", "assignment": "2024-10-02T17:12:33+02:00", "program": 72, "subprogram": null, "organization": 27477, "category": 10, "type": 10, "partner_function": 2, "manager": 50826, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "P 37331", "ethics_committee": null, "edudract_number": null, "persons": [ "8413-50826-10", "8413-128794-12", "8413-129715-12", "8413-107389-12" ] }, { "id": 8527, "title": { "de": "Metabolische Kontrolle von Altern und Krankheit", "en": "Metabolic control of aging and disease" }, "short": "MetAGE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2029-09-30T02:00:00+02:00", "end_effective": "2029-09-30T02:00:00+02:00", "assignment": "2024-11-21T16:24:26+01:00", "program": 125, "subprogram": null, "organization": 14012, "category": 10, "type": 10, "partner_function": 2, "manager": 91207, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "COE14", "ethics_committee": null, "edudract_number": null, "persons": [ "8527-91207-10", "8527-108411-12", "8527-129219-12" ] }, { "id": 8536, "title": { "de": "Metabolische Kontrolle von Altern und Krankheit", "en": "Metabolic control of aging and disease" }, "short": "METAGE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2029-09-30T02:00:00+02:00", "end_effective": "2029-09-30T02:00:00+02:00", "assignment": "2024-11-29T15:01:23+01:00", "program": 125, "subprogram": null, "organization": 14083, "category": 10, "type": 10, "partner_function": 2, "manager": 60041, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "COE14", "ethics_committee": null, "edudract_number": null, "persons": [ "8536-60041-10" ] }, { "id": 8368, "title": { "de": "pan-European Management of Biological toxin incidents through standaRdisAtion initiatives for Crisis response Enhancement", "en": "pan-European Management of Biological toxin incidents through standaRdisAtion initiatives for Crisis response Enhancement" }, "short": "EMBRACE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-08-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2027-07-31T02:00:00+02:00", "end_effective": "2027-09-30T02:00:00+02:00", "assignment": "2024-08-22T12:03:14+02:00", "program": 213, "subprogram": null, "organization": 14020, "category": 10, "type": 10, "partner_function": 2, "manager": 51663, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8368-50593-12", "8368-122831-12", "8368-126754-12", "8368-50861-12", "8368-95322-12", "8368-99430-12", "8368-101039-12", "8368-51663-10" ] }, { "id": 8426, "title": { "de": "Immunometabolic biomarkers and therapeutic targets in multiple sclerosis", "en": "Immunometabolic biomarkers and therapeutic targets in multiple sclerosis" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-09-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2026-08-31T02:00:00+02:00", "end_effective": "2026-09-30T02:00:00+02:00", "assignment": "2024-10-07T16:32:04+02:00", "program": null, "subprogram": null, "organization": 14014, "category": 10, "type": 10, "partner_function": 1, "manager": 107391, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1743 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8426-107391-10" ] }, { "id": 8312, "title": { "de": "Studying TRPC6 conformational dynamics with high-speed atomic force microscopy", "en": "Untersuchung der Konformationsdynamik von TRPC6 mit Hochgeschwindigkeits-Atomkraftmikroskopie" }, "short": null, "url": null, "abstract": { "de": "Transient-Rezeptor-Potential-Kanäle vom kanonischen Typ (TRPC) sind kalziumdurchlässige Ionenkanäle, die sowohl in erregbaren als auch in nicht-erregbaren Zellen vorkommen. TRPC-Kanäle werden durch Diacylglycerol (DAG) aktiviert, ein Produkt, das im Phospholipase-C-(PLC)-Weg nach der Spaltung von Phosphatidylinositol-4,5-bisphosphat (PIP2) gebildet wird. Bemerkenswerterweise sind, obwohl alle TRPC-Kanäle an (patho)physiologischen Prozessen beteiligt sind, nur TRPC6 als ein Schlüsselfaktor in der Entwicklung einer schweren Nierenerkrankung bekannt, die als fokal segmentale Glomerulosklerose (FSGS) bezeichnet wird. FSGS ist durch einen kontinuierlichen Kalziumleckstrom durch TRPC6 gekennzeichnet, der das Ionen-Gleichgewicht in den glomerulären Zellen stört und letztendlich zu einer Glomerulosklerose führt. Jüngste kryo-elektronenmikroskopische (Kryo-EM) Studien von TRPC6 konnten nur Strukturen von geschlossenen Kanälen erfassen und geben keine Einblicke in die Dynamik des Kanalöffnungsmechanismus, selbst in Anwesenheit von Aktivatoren. Ein Verständnis des Öffnungsmechanismus des TRPC6-Kanals zu gewinnen, wird jedoch unser Verständnis seiner pathophysiologischen Bedeutung erweitern. Darüber hinaus wird es die Grundlage für die Entwicklung pharmakologischer Strategien zur Regulierung des Kanals in nativen Geweben schaffen. Elektrophysiologische Analysen des TRPC6-Verhaltens auf Einzelkanalebene zeigten einen kurzlebigen geöffneten Zustand des Kanals. Folglich vermuten wir, dass das Kanalverhalten das Haupthindernis beim Verständnis des Öffnungsmechanismus von TRPC6-Kanälen in Kryo-EM-Studien darstellt. Hochgeschwindigkeits-Atomkraftmikroskopie (HS-AFM), eine hochmoderne Technik, hat in den letzten Jahren insbesondere bei der Untersuchung der Kanalöffnungsmechanismen von Ionenkanälen viel Aufmerksamkeit erlangt. Diese Technik ermöglicht hochauflösende und zeitlich aufgelöste topografische Bilder einer Probe, indem ihre Oberfläche gescannt wird. Kürzlich hat die Gruppe von Prof. Dr. Scheuring erfolgreich HS-AFM eingesetzt, um die Dynamik in den TRPV2- und TRPV3-Kanälen zu untersuchen. Um ein umfassendes Verständnis von TRPC6 zu erlangen und das Verhalten des Kanals in nativem Gewebe zu verstehen, werden wir die Dynamik des Kanalöffnungsmechanismus nach Stimulation mit verschiedenen Agonisten unter Verwendung von HS-AFM untersuchen.", "en": "Transient receptor potential canonical (TRPC) channels are calcium permeable ion channels found both in excitable and non-excitable cells. TRPC channels are activated by diacylglycerol (DAG), a product generated in the phospholipase C (PLC) pathway following the cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2). Notably, although all TRPC channels are involved in (patho)physiological processes, only TRPC6 has been identified as playing a pivotal role in the development of a severe kidney disease known as focal segmental glomerulosclerosis (FSGS). FSGS is characterized by continuous calcium leakage through TRPC6, which disturbs ion homeostasis within glomerular cells, ultimately resulting in glomerular sclerosis. Recent cryo-electron microscopy (cryo-EM) studies of TRPC61–3 could obtain only closed-channel structures and do not give insights into the dynamics of channel gating even in presence of activators. However, gaining an understanding of the gating mechanism of the TRPC6 channel will enhance our comprehension of its pathophysiological significance. Furthermore, it will establish a foundation for developing pharmacological strategies to regulate the channel within native tissues. Electrophysiological analysis of TRPC6 behavior on a single channel level showed a short-lived open state of the channel.4 Consequently, we hypothesized that the channel behavior is the main obstacle in gaining insights into the gating mechanism of TRPC6 channels during cryo-EM. High-speed atomic force microscopy (HS-AFM), a state-of-the-art technique, has gained high attention in recent years especially in studying ion channel gating. This technique allows high-resolution and time resolved topographic images of a sample by scanning its surface. Recently the group of Prof. Dr. Scheuring, successfully employed HS-AFM to study the dynamics in TRPV25 and TRPV36 ion channels. To gain a comprehensive understanding of TRPC6 and understand the behavior of the channel in native tissue we will study the dynamics of channel gating upon stimulation with different agonists using HS-AFM. " }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2026-09-30T02:00:00+02:00", "end_effective": "2026-09-30T02:00:00+02:00", "assignment": "2024-07-26T11:43:41+02:00", "program": 116, "subprogram": null, "organization": 14011, "category": 10, "type": 10, "partner_function": 4, "manager": 116421, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 15 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8312-116421-10", "8312-73077-12", "8312-78591-12", "8312-90337-12", "8312-98848-12" ] }, { "id": 8506, "title": { "de": "Medizinische Entscheidungen bei der Multisystematrophie: Entwicklung einer\r\npersonalisierten, bestmöglichen medizinischen Versorgung mit integrierter Telemedizin und\r\nmobiler Palliativversorgung für Personen mit Multisystematrophie- Eine monozentrische,\r\nrandomisierte, offene klinische Studie mit verblindeter Bewertung der motorischen Progression\r\nwährend des Interventionszeitraums", "en": "Medical Decision Making in Multiple System Atrophy: developing personalized best medical care with integrated telemedicine and mobile palliative care for individuals with multiple system atrophy - A monocentric, randomized, open-label clinical study with rater\u0002blinded evaluation of motor progression over the interventional period" }, "short": "MeDeMSA Care", "url": null, "abstract": { "de": "Das Lebensende stellt MSA-Patienten, ihre Betreuer und behandelnden Ärzte vor zahlreiche ethische Dilemmata: Vorenthaltung oder Entzug von Medikamenten, Nahrungsverweigerung vs. Gastrostomie, invasive Beatmung, Anordnung der Nicht-Wiederbelebung. \r\nAdvanced Care Planning (ACP) ist ein wichtiger fortlaufender Kommunikationsprozess, bei dem Patienten das klinische Team über ihre Werte, Ziele und Präferenzen bei der medizinischen Behandlung während schwerer und chronischer Krankheiten informieren können. ACP ist ein Instrument zur Förderung der Autonomie von Patienten und ihres individuellen Konzepts von Lebensqualität (QoL), aber die ethische Perspektive wurde in der besonderen Situation von Menschen, die mit MSA leben, noch nicht systematisch in den Blick genommen.\r\nDie wichtigsten Forschungsfragen in diesem Projekt sind: Welche Wünsche und Vorstellungen haben Menschen mit MSA von einem würdigen Lebensende? Wie ist es möglich, die Lebensqualität dieser Menschen und ihrer Betreuer zu verbessern?\r\nUm diese Fragen zu beantworten, werden Menschen mit MSA und ihre Betreuer, die für die Interventionsstudie MeDeMSA PA3 rekrutiert wurden, zu halbstrukturierten Interviews zu Beginn der Studie und 12 Monate nach den Interventionsmaßnahmen eingeladen (Kallio, Pietilä, Johnson, & Kangasniemi, 2016). \r\nZiel ist es, die Präferenzen der Patienten und des Pflegepersonals in Bezug auf die Beteiligung an Entscheidungen in der Gesundheitsversorgung zu bewerten, welche Art der Informationsvermittlung für ihren Entscheidungsprozess relevant ist, wie sie Telemedizin und mobile Palliativversorgung wahrnehmen, deren rechtliche und regulatorische Aspekte und schließlich ihre Sicht auf die Arzt-Patienten-Beziehung und ihr Konzept der Lebensqualität, das für die ACP wesentlich ist.\r\nUm diese Ziele zu erreichen, sind folgende Arbeitsschritte geplant: i. Eine systematische Übersicht über den ethischen und Stand der Technik in Bezug auf die gemeinsame Entscheidungsfindung, ethische Richtlinien, ACP, Gesetze und Vorschriften in Bezug auf Lebensende und Palliativversorgung bei neurodegenerativen Erkrankungen; ii. eine Umfrage zum Autonomie-Präferenz-Index bei Menschen mit MSA, die in PA3 rekrutiert wurden, und deren Betreuer; iii. ein dynamischer Beitrag zu den klinischen MeDeMSA Sitzungen des klinischen MeDeMSA-Ausschusses; iv. eine eingehende Beschäftigung mit der Telemedizin für Menschen mit MSA und die Bewertung ihrer und ethischen Aspekte und die Entwicklung eines bioethischen Rahmens und von Aufklärungsmaterial für MSA-Patienten und ihre Betreuer. In ständiger enger Zusammenarbeit mit den anderen PA der MeDeMSA RG ist es das Ziel einen bioethischen Rahmen für patientenzentrierte medizinische Entscheidungen im MeDeMSA-Versorgungskreis zu schaffen.", "en": "End of life challenges MSA patients, their caregivers and treating physicians with many ethical dilemmas: withholding or withdrawing medications, food refusal vs. gastrostomy feeding, invasive ventilation, the do\u0002not-resuscitate order. \r\nAdvanced care planning (ACP) is an important ongoing process of communication, where patients can inform the clinical team about their values, goals and preferences in medical treatment during serious and chronic illness. ACP is an instrument to promote autonomy of patients and their individual concept of quality of life (QoL), but the ethical perspective has not been systematically focused on in the peculiar setting of people living with MSA yet.\r\nThe main research questions in this PA are: what are the wishes and perceptions of a decent end-of-life for people living with MSA? How is it possible to improve the QoL of these people and their caregivers?To answer these questions, people with MSA and their care-givers recruited in the interventional trial of MeDeMSA PA3 will be invited to join semi-structured interviews at the study begin and 12 months into the interventional procedures (Kallio, Pietilä, Johnson, & Kangasniemi, 2016). \r\nThe aim is to evaluate the patients’ and caregivers’ preferences for involvement in health-care decisions, which kind of information communication is \r\nrelevant for their decision-making process, which is their perception of telemedicine and mobile palliative care, the legal and regulatory aspects thereof and, ultimately, their perspectives on the patient–physician relationship and their concept of QoL, which is essential for ACP.\r\nTo achieve these goals the following worksteps are planned: i. A systematic review of the ethical and regulatory state of the art on shared-decision making, ethical guidelines, ACP, laws and regulations related to end-of life and palliation in neurodegenerative disorders; ii. an Autonomy Preference Index survey of people with MSA recruited in PA3 and their care-givers; iii. a dynamic contribution to the clinical MeDeMSA board meetings; iv. an in-depth focus on telemedicine for people with MSA and the assessment of its regulatory and ethical aspects and v. the development of a bioethical framework and educational material for MSA patients and their caregivers. In permanent close cooperation with the other PA of the MeDeMSA RG, the aim of PA5 is to establish a bioethical framework for patient-centered medical decisions in the MeDeMSA circle of care." }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2028-03-31T02:00:00+02:00", "end_effective": "2028-03-31T02:00:00+02:00", "assignment": "2024-11-19T16:44:54+01:00", "program": 113, "subprogram": null, "organization": 14051, "category": 10, "type": 10, "partner_function": 4, "manager": 50172, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "FG 2705 - B ", "ethics_committee": null, "edudract_number": null, "persons": [ "8506-50172-10" ] }, { "id": 8484, "title": { "de": "Genome of Europe\r\n", "en": "Genome of Europe\r\n" }, "short": "GoE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2027-04-30T02:00:00+02:00", "end_effective": "2028-03-31T02:00:00+02:00", "assignment": "2024-11-08T14:33:55+01:00", "program": 214, "subprogram": null, "organization": 14021, "category": 10, "type": 10, "partner_function": 2, "manager": 50899, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10, 416 ], "funder_projectcode": "101168231", "ethics_committee": null, "edudract_number": null, "persons": [ "8484-50899-10" ] }, { "id": 8127, "title": { "de": "LYVE-1 Hofbauer-Zellen bei Präeklampsie", "en": "LYVE-1 Hofbauer cells in preeclampsia" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-03-01T01:00:00+01:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2027-02-28T01:00:00+01:00", "end_effective": "2027-09-30T02:00:00+02:00", "assignment": "2024-04-05T10:35:43+02:00", "program": 111, "subprogram": null, "organization": 14017, "category": 10, "type": 10, "partner_function": 4, "manager": 53232, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "I06907", "ethics_committee": null, "edudract_number": null, "persons": [ "8127-106163-12", "8127-119494-12", "8127-126134-12", "8127-53232-10", "8127-90214-12", "8127-93683-12", "8127-98902-12" ] }, { "id": 8370, "title": { "de": "pan-European Management of Biological toxin incidents through standaRdisAtion initiatives for Crisis response Enhancement (EMBRACE)", "en": "pan-European Management of Biological toxin incidents through standaRdisAtion initiatives for Crisis response Enhancement (EMBRACE)" }, "short": "EMBRACE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2027-09-30T02:00:00+02:00", "end_effective": "2027-09-30T02:00:00+02:00", "assignment": "2024-08-22T12:04:16+02:00", "program": 211, "subprogram": null, "organization": 29444, "category": 10, "type": 10, "partner_function": 2, "manager": 50654, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8370-50654-10" ] }, { "id": 8526, "title": { "de": "Metabolische Kontrolle von Altern und Krankheit", "en": "Metabolic control of aging and disease" }, "short": "MetAGE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2023-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2028-09-30T02:00:00+02:00", "end_effective": "2029-09-30T02:00:00+02:00", "assignment": "2024-11-21T16:12:55+01:00", "program": 125, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 4, "manager": 71487, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "COE14", "ethics_committee": null, "edudract_number": null, "persons": [ "8526-116490-12", "8526-119268-12", "8526-127474-12", "8526-71487-10" ] }, { "id": 8395, "title": { "de": "Identifying novel lung cancer drivers: Unravelling the functional role of genes affected by large copy number gains\r\n", "en": "Identifying novel lung cancer drivers: Unravelling the functional role of genes affected by large copy number gains\r\n" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2025-01-01T01:00:00+01:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2026-12-31T01:00:00+01:00", "end_effective": "2026-12-31T01:00:00+01:00", "assignment": "2024-09-23T13:30:15+02:00", "program": null, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 109002, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 1888 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8395-98327-12", "8395-109501-11", "8395-111070-11", "8395-109002-10" ] }, { "id": 8294, "title": { "de": "Der Zusammenhang zwischen Körpergewicht und kortikaler Neuroplastizität und Lernen – eine Pilotstudie", "en": "The relationship between Body Weight and Human Motor Cortical Plasticity and Learning" }, "short": null, "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2025-12-31T01:00:00+01:00", "end_effective": "2025-12-31T01:00:00+01:00", "assignment": "2024-07-10T16:17:43+02:00", "program": null, "subprogram": null, "organization": 14010, "category": 10, "type": 10, "partner_function": 4, "manager": 58643, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 2471 ], "funder_projectcode": "FIF-A 16-0532/2024-0001", "ethics_committee": null, "edudract_number": null, "persons": [ "8294-58643-10" ] }, { "id": 8218, "title": { "de": "TWINNING FOR EXCELLENCE TO ADVANCE RESEARCH IN THE ACTIVATION OF\r\nANTI-TUMOR IMMUNE RESPONSE AFTER ELECTROCHEMOTHERAPY COMBINED WITH GENE\r\nELETROTRANSFER OF pDNA ENCODING ICIs", "en": "TWINNING FOR EXCELLENCE TO ADVANCE RESEARCH IN THE ACTIVATION OF\r\nANTI-TUMOR IMMUNE RESPONSE AFTER ELECTROCHEMOTHERAPY COMBINED WITH GENE\r\nELETROTRANSFER OF pDNA ENCODING ICIs" }, "short": "ZAP Cancer", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2027-04-30T02:00:00+02:00", "end_effective": "2027-09-30T02:00:00+02:00", "assignment": "2024-05-17T13:23:37+02:00", "program": null, "subprogram": null, "organization": 14085, "category": 10, "type": 10, "partner_function": 4, "manager": 107132, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 10 ], "funder_projectcode": "101160061", "ethics_committee": null, "edudract_number": null, "persons": [ "8218-109501-12", "8218-107132-10", "8218-109002-11" ] }, { "id": 8602, "title": { "de": "CoE MetAge – Zusatzfinanzierung", "en": "CoE MetAge – Zusatzfinanzierung" }, "short": "CoE MetAge – Zusatzfinanzierung", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2029-09-30T02:00:00+02:00", "end_effective": "2029-09-30T02:00:00+02:00", "assignment": "2025-01-17T11:19:47+01:00", "program": null, "subprogram": null, "organization": 14012, "category": 10, "type": 10, "partner_function": 2, "manager": 91207, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 135 ], "funder_projectcode": "ABT12-338847/2024-12", "ethics_committee": null, "edudract_number": null, "persons": [ "8602-91207-10" ] }, { "id": 8478, "title": { "de": "Veränderung menschlicher Eosinophiler Granulozyten im Alter abhängig vom Geschlecht", "en": "Phenotypic changes of eosinophil granulocytes in aging and sex" }, "short": "Eosinph. Granulozyten_Alter_Geschlecht", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2025-09-30T02:00:00+02:00", "end_effective": "2025-09-30T02:00:00+02:00", "assignment": "2024-11-06T09:30:06+01:00", "program": null, "subprogram": null, "organization": 14022, "category": 10, "type": 10, "partner_function": 4, "manager": 85658, "contact": null, "status": 2, "research": 1, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 457 ], "funder_projectcode": null, "ethics_committee": null, "edudract_number": null, "persons": [ "8478-85658-10" ] }, { "id": 8524, "title": { "de": "Metabolische Kontrolle von Altern und Krankheit: Von Modellen zum Menschen", "en": "Metabolic control of aging and disease: From Models to humans" }, "short": "MetAGE", "url": null, "abstract": { "de": null, "en": null }, "begin_planned": "2024-10-01T02:00:00+02:00", "begin_effective": "2024-10-01T02:00:00+02:00", "end_planned": "2029-09-30T02:00:00+02:00", "end_effective": "2029-09-30T02:00:00+02:00", "assignment": "2024-11-21T16:12:22+01:00", "program": 125, "subprogram": null, "organization": 14080, "category": 10, "type": 10, "partner_function": 1, "manager": 51831, "contact": null, "status": 2, "research": 2, "grant": 10, "event": null, "study": null, "language": null, "funders": [ 9 ], "funder_projectcode": "COE14", "ethics_committee": null, "edudract_number": null, "persons": [ "8524-51831-10" ] } ] }